Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2025/06/089402
CTRI/2025/06/089402Not yet recruitingPhase 2

Randomized controlled trial to evaluate the efficacy of Dheeradi Ghrita in the management of Attention Deficit Hyperactivity Disorder(ADHD) in children of age group 6 to 12 years

Anjali Pratap Thawrani1 site in 1 country60 target enrollmentStarted: September 7, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
To study the effect of Dheeradi Ghrita in ADHD
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

This study is a randomized open labelled controlled clinical trial comparing the safety and efficacy of Dheeradi ghrita 4ml thrice a day  with koshna jala and controlled shankhpushpi and jatamansi siddha ghrita 4ml thrice a day with koshna jala for 45 days in 60 children of age group 6 to 12 yrs with Attention Deficit Hyperactivity Disorder (ADHD)

Study Design

Study Type
Interventional
Allocation
Coin toss, Lottery, toss of dice, shuffling cards etc
Masking
Open Label

Eligibility Criteria

Ages
6.00 Year(s) to 12.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Age group between 6 to 12 yrs.
  • •Patient irrespective of their gender, religion and socioeconomic status.
  • •Patients having Symptoms of ADHD for at least last 6 months.
  • •Patients that fit in DSM IV criteria for diagnosis.
  • •Children with no other neurological condition like mental retardation, down syndrome, microcephaly, etc.

Exclusion Criteria

  • •Any serious neurological disease diagnosed earlier like cerebral palsy, mental retardation, microcephaly.
  • •Any kind of systemic disease or chronic systemic disease like nephrotic syndrome, type 1 diabetes melitus.
  • •disobedient parents.

Outcomes

Primary Outcomes

To study the effect of Dheeradi Ghrita in ADHD

Time Frame: 15 days

Secondary Outcomes

  • To understand the disease ADHD in detail.(To find out ayurvedic correlation of disease with doshas and dushya.)

Investigators

Sponsor
Anjali Pratap Thawrani
Sponsor Class
Other [self]

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 3
Neoadjuvant Chemo-endocrine Therapy Versus Chemotherapy Alone in ER-positive, HER2-negative Breast CancerBreast Cancer Female
NCT02980965Fudan University249
Terminated
Not Applicable
A Randomized Controlled Open Label Trial to Assess the Safety and Efficacy of the OptiVein IV Catheter in an Oncologic PopulationIntravenous Injections
NCT02420028Optomeditech Oy109
Completed
Phase 3
Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan ChildrenPlasmodium Falciparum
NCT03452475University of Oxford219
Unknown
Not Applicable
Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) vs (Standard AN-69) in COVID-19Covid19AKI
NCT04597034Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran35
Active, not recruiting
Not Applicable
Coronary Artery Disease Reversal Treatment for patients suffering from Coronary Artery Disease.
CTRI/2018/09/015633Vaidya Sane Ayurvedic Lab Pvt Ltd30